FIP1L1
Basic information
Region (hg38): 4:53377569-53464382
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FIP1L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 6 | |||||
Total | 0 | 0 | 21 | 1 | 1 |
Variants in FIP1L1
This is a list of pathogenic ClinVar variants found in the FIP1L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-53377893-G-A | not specified | Uncertain significance (May 11, 2022) | ||
4-53379088-A-G | not specified | not provided (Sep 19, 2013) | ||
4-53383804-G-A | not specified | Uncertain significance (May 25, 2022) | ||
4-53390521-G-T | not specified | Uncertain significance (Jan 23, 2024) | ||
4-53390575-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
4-53391045-A-T | not specified | Uncertain significance (Apr 20, 2024) | ||
4-53391053-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
4-53391054-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
4-53391078-A-T | not specified | Uncertain significance (May 06, 2022) | ||
4-53391104-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
4-53391110-C-G | not specified | Uncertain significance (Nov 21, 2023) | ||
4-53391488-A-G | not specified | not provided (Sep 19, 2013) | ||
4-53399787-G-A | not specified | Uncertain significance (Jun 18, 2024) | ||
4-53399808-T-C | not specified | Uncertain significance (Oct 20, 2023) | ||
4-53399809-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
4-53399834-G-A | Likely benign (Mar 01, 2023) | |||
4-53414665-A-G | not specified | Uncertain significance (Feb 27, 2023) | ||
4-53414706-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
4-53428048-A-G | not specified | Uncertain significance (May 23, 2024) | ||
4-53444114-T-G | not specified | Benign (Feb 21, 2013) | ||
4-53453014-C-A | not specified | Uncertain significance (Sep 16, 2021) | ||
4-53453045-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
4-53453104-T-A | not specified | Uncertain significance (May 20, 2024) | ||
4-53458645-A-C | Likely benign (Mar 01, 2023) | |||
4-53458653-C-T | not specified | Likely benign (May 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FIP1L1 | protein_coding | protein_coding | ENST00000337488 | 18 | 917630 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.789 | 0.211 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.07 | 178 | 336 | 0.530 | 0.0000182 | 3885 |
Missense in Polyphen | 68 | 155.5 | 0.4373 | 1751 | ||
Synonymous | -1.01 | 123 | 110 | 1.12 | 0.00000591 | 1124 |
Loss of Function | 4.72 | 8 | 40.4 | 0.198 | 0.00000266 | 418 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000931 | 0.0000905 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000621 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre- mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. FIP1L1 contributes to poly(A) site recognition and stimulates poly(A) addition. Binds to U-rich RNA sequence elements surrounding the poly(A) site. May act to tether poly(A) polymerase to the CPSF complex. {ECO:0000269|PubMed:14749727}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving FIP1L1 is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). {ECO:0000269|PubMed:12660384, ECO:0000269|PubMed:12808148}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);Gene expression (Transcription);RNA Polymerase II Transcription;Metabolism of RNA;Processing of Intronless Pre-mRNAs;Processing of Capped Intronless Pre-mRNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;mRNA Splicing;mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.235
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.44
Haploinsufficiency Scores
- pHI
- 0.654
- hipred
- Y
- hipred_score
- 0.716
- ghis
- 0.689
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fip1l1
- Phenotype
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA polyadenylation;mRNA export from nucleus;mRNA 3'-end processing;pre-mRNA cleavage required for polyadenylation
- Cellular component
- nucleoplasm;mRNA cleavage and polyadenylation specificity factor complex
- Molecular function
- RNA binding;protein binding